134 related articles for article (PubMed ID: 20944170)
1. Evaluation of FDG-PET for detecting lymph node metastasis in uterine corpus cancer.
Klar M; Meyer PT; Hancke K; Brink I; Orlowska-Volk M; Gitsch G; Denschlag D
Anticancer Res; 2010 Sep; 30(9):3787-90. PubMed ID: 20944170
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
Horowitz NS; Dehdashti F; Herzog TJ; Rader JS; Powell MA; Gibb RK; Grigsby PW; Siegel BA; Mutch DG
Gynecol Oncol; 2004 Dec; 95(3):546-51. PubMed ID: 15581961
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings.
Inubashiri E; Hata K; Kanenishi K; Shiota A; Ohno M; Yamamoto Y; Nishiyama Y; Ohkawa M; Hata T
J Obstet Gynaecol Res; 2009 Feb; 35(1):26-34. PubMed ID: 19215544
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer.
Park JY; Kim EN; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2008 Mar; 108(3):486-92. PubMed ID: 18201753
[TBL] [Abstract][Full Text] [Related]
5. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
[TBL] [Abstract][Full Text] [Related]
7. [18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy.
Dräger DL; Heuschkel M; Protzel C; Erbersdobler A; Krause BJ; Hakenberg OW; Schwarzenböck SM
Nuklearmedizin; 2018 Feb; 57(1):26-30. PubMed ID: 29536497
[TBL] [Abstract][Full Text] [Related]
8. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group.
Wahl RL; Siegel BA; Coleman RE; Gatsonis CG;
J Clin Oncol; 2004 Jan; 22(2):277-85. PubMed ID: 14722036
[TBL] [Abstract][Full Text] [Related]
9. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
Konuralp Atakul B; Taşkın S; Soydal Ç; Sükür YE; Kahraman A; Koyuncu K; İbiş E; Ortac F
Gynecol Obstet Invest; 2017; 82(4):340-348. PubMed ID: 27771729
[TBL] [Abstract][Full Text] [Related]
10. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
11. Comparison of MRI and 18F-FDG PET/CT in the preoperative evaluation of uterine carcinosarcoma.
Lee HJ; Park JY; Lee JJ; Kim MH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2016 Mar; 140(3):409-14. PubMed ID: 26777990
[TBL] [Abstract][Full Text] [Related]
12. Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study.
Roh JW; Seo SS; Lee S; Kang KW; Kim SK; Sim JS; Kim JY; Hong EK; Cho DS; Lee JS; Park SY
Eur J Cancer; 2005 Sep; 41(14):2086-92. PubMed ID: 16125928
[TBL] [Abstract][Full Text] [Related]
13. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutch DG; Powell MA; Grigsby PW
J Clin Oncol; 2010 Apr; 28(12):2108-13. PubMed ID: 20308664
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer].
Yang WF; Tan GZ; Fu Z; Yu JM
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):925-8. PubMed ID: 20193335
[TBL] [Abstract][Full Text] [Related]
15. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT.
Sironi S; Buda A; Picchio M; Perego P; Moreni R; Pellegrino A; Colombo M; Mangioni C; Messa C; Fazio F
Radiology; 2006 Jan; 238(1):272-9. PubMed ID: 16304090
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study.
Rose PG; Adler LP; Rodriguez M; Faulhaber PF; Abdul-Karim FW; Miraldi F
J Clin Oncol; 1999 Jan; 17(1):41-5. PubMed ID: 10458216
[TBL] [Abstract][Full Text] [Related]
17. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
Kato T; Tsukamoto E; Kuge Y; Katoh C; Nambu T; Nobuta A; Kondo S; Asaka M; Tamaki N
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1047-54. PubMed ID: 12173019
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
[TBL] [Abstract][Full Text] [Related]
19. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET.
Reinhardt MJ; Ehritt-Braun C; Vogelgesang D; Ihling C; Högerle S; Mix M; Moser E; Krause TM
Radiology; 2001 Mar; 218(3):776-82. PubMed ID: 11230656
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients.
Heusner TA; Kuemmel S; Hahn S; Koeninger A; Otterbach F; Hamami ME; Kimmig KR; Forsting M; Bockisch A; Antoch G; Stahl A
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1543-50. PubMed ID: 19415270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
